The Role of Medical Affairs in Rare Disease
This podcast, recorded at the MAPS 2022 Global Annual Meeting, addresses the unique position of Medical Affairs in the rare disease space & how our work in this area is essential for patient benefit.
Has Medical Affairs Truly Achieved a Position as the Third Strategic Pillar?
Charlotte Kremer (former Astellas) speaks with Danie du Plessis (Kyowa Kirin) and Bjorn Oddens (Merck) about whether Medical Affairs is truly the third strategic pillar.
Leadership Perspectives – Medical Affairs as a Strategic Business Partner
In this installment of the Leadership Perspectives series, we speak with some of the top Medical Affairs leaders from Johnson & Johnson as they think about the rapid new ascension of Medical Affairs into a fully integrated strategic business partner.
Medical Affairs 2030: The Future of the Function
MAPS speaks with Ariel Katz, co-founder and CEO of H1, about the factors driving the evolution of Medical Affairs and look at the shape of the function in 2030 and beyond.
MAPS 2021 Industry Benchmarking Report
This 2021 Benchmark Report is based on findings from 21 leading industry organizations regarding their organizational structure, budget, and operations.
From Support Function to a Strategic Pillar, Medical Affairs is Defying Convention by Breaking Down Silos
In this dynamic and conversational webinar, we will review how adaptive connected technology and processes support our mandate to deliver integrated evidence that articulates clear clinical and economic value to improve patient experience and outcomes.
Why Good Science is Good Business: A Conversation with Murali Gopal, MD
Murali Gopal, MD, discusses the power of Integrated Brand Planning to transform the Medical Affairs function within the biopharmaceutical industry
Eileen Sawyer: Big Reader, Science Nerd and Medical Affairs Leader in Gene Therapy
Sawyer is making it her life’s work to focus on the patient—the most important stakeholder in drug development.
The Future of Medical Affairs: A Conversation with Beat Sümegi, SVP Medical, Sanofi
MAPS speaks with Beat Sümegi, SVP Medical with Sanofi, about major areas of change and the need to help Medical Affairs professionals build new skills to succeed in this world of increased responsibility and opportunity.
Interview: Medical Affairs as a Strategic Partner to Achieve Better Patient Outcomes
Eileen Sawyer, VP, Global Medical Affairs at uniQure, describes the importance of Medical Affairs acting as a strategic partner, how to effectively engage patients throughout the drug development process, and to ultimately achieve better patient outcomes.